Navigation Links
Actavis, Inc. to Present at the Goldman Sachs 34th Annual Global Healthcare Conference 2013
Date:6/4/2013

PARSIPPANY, N.J., June 4, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, announced today that Paul Bisaro , Actavis' President and Chief Executive Officer, will provide an overview and update of the Company's business at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12, 2013 at 8:00 AM Pacific Time at the Terranea Resort, Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed on Actavis' Investor Relations Web site at http://ir.actavis.com.  The webcast can also be accessed at the following URL:

http://cc.talkpoint.com/gold006/061113a_gm/reports.asp?entity=3_MP7DP11

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Actavis, Inc.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  Actavis has global headquarters in Parsippany, New Jersey, USA. 

Operating as Actavis Pharma, Actavis develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries.  Actavis Specialty Brands is Actavis' global branded specialty pharmaceutical business focused in the Urology and Women's Health therapeutic categories.  Actavis Specialty Brands also has a portfolio of five biosimilar products in development in Women's Health and Oncology.  Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.

For press release and other company information, visit Actavis' Web site at http://www.actavis.com.CONTACTS:Investors:Lisa DeFrancesco(862) 261-7152Media:Charlie Mayr(862) 261-8030(Logo: http://photos.prnewswire.com/prnh/20130124/NY47381LOGO)


'/>"/>
SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
2. Actavis, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
4. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
5. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
6. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
9. PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
10. CVS Caremark To Present At William Blair & Companys 33rd Annual Growth Stock Conference
11. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... March 28, 2017 RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Japan Patent Office (JPO) for the composition ... factor (CTGF) for the treatment or prevention of ... fibrosis and proliferative retinopathy (Japanese Patent #: 6060071).  ...
(Date:3/28/2017)... 2017 The global flow ... billion by 2025, according to a new study by ... diseases and cancer is expected to upsurge the demand ... the coming years. In addition, higher number of physicians ... stem cell therapy, due to adverse effects caused by ...
(Date:3/28/2017)... Elysium Health joins major pharmaceutical companies to ... Cambridge academic scientists through ... Institute today announces Elysium Health as a partner to the ... collaborative projects with academic researchers in Cambridge ... major research investment outside the U.S. for the ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... MA (PRWEB) , ... March 28, 2017 , ... ... for direct measurement of corrosive ions found in power plant water and steam. ... components such as turbines and boilers, leading to extensive maintenance and unplanned shutdowns. ...
(Date:3/28/2017)... ... 2017 , ... A minimally invasive porcelain veneer is increasing ... Association of Dental Laboratories (NADL) is informing dentists about the benefits of minimally ... dental laboratories and technicians that create these veneers. , According to National ...
(Date:3/28/2017)... NJ (PRWEB) , ... March 28, 2017 , ... ... Camp Association’s Tri-State Camp Conference in Atlantic City March 13-16, was a busy ... their team of professional staff discussed strategies for preventing outbreaks among camp communities ...
(Date:3/28/2017)... ... ... Thank you to all who attended Capio Partners Winter 2017 Healthcare Leadership Symposium ... providers and offered an opportunity to collaborate and network with healthcare colleagues across the ... attendees gathered for a lively discussion on trends and issues that healthcare leaders will ...
Breaking Medicine News(10 mins):